米诺环素在抑郁症中的有效性:系统性审查和元分析
Hua Huang1, Zhuan Zou, Bin Chen
1Longquanyi District of Chengdu Maernal and Child Health Care Hospital, Chengdu, China.
Clinical neuropharmacology
|November 26, 2024
概括
在随机对照试验的元分析中,米诺环素没有显著降低抑郁症症状. 需要进一步的研究来探索替代性抗抑郁药疗法,以应对不充分的治疗反应.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的抗抑郁药疗法往往产生不充分的反应和低缓解率.
- 需要新的治疗策略来治疗抑郁症.
研究的目的:
- 综合来自随机对照试验 (RCT) 的证据,评估米诺环素作为抑郁症辅助治疗的疗效.
主要方法:
- 进行了主要数据库 (PubMed,科学网,Embase,科克兰图书馆) 的系统搜索.
- 包括使用汉密尔顿抑郁评分表 (HDRS) 或蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 评估米诺环素对抑郁的影响的RCT.
- 分析汇总了HDRS/MADRS变化,以比较米诺环素与安慰剂;研究质量使用Cochrane风险偏差工具进行评估.
主要成果:
- 涉及567名参与者的8个RCT符合纳入标准.
- 根据HDRS或MADRS得分,元分析发现,与安慰剂相比,米诺环素没有统计学上显著的抗抑郁作用.
结论:
- 当通过HDRS和MADRS得分进行评估时,米诺环素在缓解抑郁症状方面没有显著的有效性.
- 根据目前的证据,这些发现表明米诺环不是一种可行的抑郁症治疗选择.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Depression: Overview
216
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
216
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
309
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
309
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antidepressant Drugs: Overview
360
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
360


